| Literature DB >> 10836043 |
W M Clark1, A J Kassick, M A Plotkin, A M Eldridge, I Lantos.
Abstract
[formula: see text] The bakers' yeast reduction of 3-(1,3-benzodioxol-5-yl)-6-propoxy-1H-inden-1-one 4 has been shown to give (S)-3-(1,3-benzodioxol-5-yl)-2,3-dihydro-6-propoxy-1H-indan-1-one 6 in 65% yield with high enantioselectivity (> 99.0% ee), a key intermediate for the synthesis of the endothelin receptor antagonist SB 217242. In addition, the substituted 3-arylinden-1-ones 10a-e gave equally high enantioselectivity for the 3-arylindan-1-one products 13a-e. Mechanistic studies of the reaction indicate the operative pathway to be an asymmetric conjugate reduction, wherein the hydride transfer from NAD(P)H occurs from the Re-face of the indenone substrate.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10836043 DOI: 10.1021/ol991111+
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005